Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for TEVA-OMEPRAZOLE

Brand name

TEVA-OMEPRAZOLE

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02295415

Ingredients & Strength

OMEPRAZOLE (20 MG)

Anatomical Therapeutical Chemical (ATC) Code

A02BC

Anatomical Therapeutical Chemical (ATC) Descriptor

DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
TEVA-OMEPRAZOLE	500	Resolved	2024-09-12	2025-12-02	237473
TEVA-OMEPRAZOLE	100	Actual shortage	2024-11-08	2026-02-05	242358
TEVA-OMEPRAZOLE	500	Actual shortage	2025-12-04	2026-02-05	273293

Showing 11 to 13 of 13

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0

Reports for TEVA-OMEPRAZOLE

Brand name TEVA-OMEPRAZOLE

Brand name

TEVA-OMEPRAZOLE